Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GNMK | TMO | ISRG | EW | IDXX |
| Company | Genmark Diagnostics | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Idexx Laboratories |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 24.04 | 567.94 | 368.10 | 87.00 | 484.03 |
| High | 24.06 | 575.00 | 377.83 | 88.38 | 497.95 |
| Low | 24.03 | 566.95 | 368.10 | 84.71 | 484.03 |
| Last | 24.04 | 574.61 | 377.00 | 86.38 | 497.13 |
| Change | unch | +2.88 | +3.88 | -1.63 | +7.89 |
| % Change | unch | +0.50% | +1.04% | -1.85% | +1.61% |
| Volume | 3,825,600 | 684,106 | 408,006 | 2,946,533 | 228,680 |
| 20-Day Average Volume | 3,099,570 | 1,349,376 | 1,583,894 | 3,025,053 | 426,316 |
| Previous Close | 24.04 | 571.73 | 373.12 | 88.01 | 489.24 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 23.99 | 567.43 | 380.51 | 90.02 | 501.14 |
| 20-Day Raw Stochastic | 48.15% | 73.58% | 32.31% | 13.16% | 36.73% |
| 20-Day Relative Strength | 65.80% | 52.73% | 46.54% | 42.85% | 41.87% |
| Weighted Alpha | +47.71 | +8.08 | +26.38 | +3.56 | +0.08 |
| Today's Opinion | 100% Buy | 72% Buy | 40% Buy | 40% Buy | 56% Sell |
| Previous Opinion | 100% Buy | 56% Buy | 40% Buy | 56% Buy | 56% Sell |
| Last Month's Opinion | 100% Buy | 80% Buy | 100% Buy | 88% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.21% since 04/14/21 | +5.36% since 04/19/24 | +2.54% since 04/19/24 | +0.26% since 04/19/24 | +4.44% since 04/19/24 |
| Low | 23.98 on 04/15/21 | 543.15 on 04/22/24 | 364.31 on 04/22/24 | 84.71 on 04/26/24 | 473.86 on 04/22/24 |
| High | 24.08 on 04/19/21 | 586.46 on 04/24/24 | 383.62 on 04/24/24 | 89.17 on 04/24/24 | 497.49 on 04/26/24 |
| 1-Month | |||||
| %Chg | unch since 03/19/21 | +0.91% since 03/26/24 | -5.53% since 03/26/24 | -7.77% since 03/26/24 | -6.24% since 03/26/24 |
| Low | 23.84 on 04/12/21 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 84.71 on 04/26/24 | 471.42 on 04/19/24 |
| High | 24.25 on 03/26/21 | 589.93 on 04/09/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 543.33 on 03/28/24 |
| 3-Month | |||||
| %Chg | +64.21% since 01/21/21 | +4.87% since 01/26/24 | +0.23% since 01/26/24 | +17.64% since 01/26/24 | -5.24% since 01/26/24 |
| Low | 12.76 on 01/29/21 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 72.71 on 01/29/24 | 471.42 on 04/19/24 |
| High | 24.25 on 03/26/21 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 583.39 on 03/01/24 |
| 6-Month | |||||
| %Chg | +116.77% since 10/21/20 | +30.41% since 10/26/23 | +44.75% since 10/26/23 | +37.24% since 10/26/23 | +25.18% since 10/26/23 |
| Low | 10.88 on 10/22/20 | 420.21 on 10/30/23 | 254.85 on 10/30/23 | 60.57 on 10/30/23 | 372.50 on 11/01/23 |
| High | 24.25 on 03/26/21 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 583.39 on 03/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,756,987 | 218,237,344 | 132,347,904 | 52,975,596 | 40,633,336 |
| Shares Outstanding, K | 73,086 | 381,714 | 354,706 | 601,927 | 83,054 |
| Annual Sales | 171,550,000 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,660,950,000 |
| Annual Net Income | -18,640,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 845,040,000 |
| Last Quarter Sales | 50,080,000 | 10,886,000,000 | 1,890,600,000 | 1,534,100,000 | 901,600,000 |
| Last Quarter Net Income | -3,720,000 | 1,630,000,000 | 544,900,000 | 369,900,000 | 194,520,000 |
| 60-Month Beta | 3.05 | 0.80 | 1.36 | 1.05 | 1.26 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.11 on 04/24/24 | 1.50 on 04/18/24 | 0.66 on 04/25/24 | 2.32 on 02/05/24 |
| Latest Earnings Date | 05/03/21 | 04/24/24 | 04/18/24 | 04/25/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.71 | 80.13 | 35.30 | 49.08 |